{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:01:52Z","timestamp":1761807712078},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2011,11,26]],"date-time":"2011-11-26T00:00:00Z","timestamp":1322265600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s00198-011-1848-y","type":"journal-article","created":{"date-parts":[[2011,11,25]],"date-time":"2011-11-25T16:10:17Z","timestamp":1322237417000},"page":"2387-2391","source":"Crossref","is-referenced-by-count":8,"title":["De novo autoimmune hepatitis associated with PTH(1\u201334) and PTH(1\u201384) administration for severe osteoporosis in a liver transplant patient"],"prefix":"10.1007","volume":"23","author":[{"given":"P.","family":"Anagnostis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z. A.","family":"Efstathiadou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Akriviadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Hytiroglou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,26]]},"reference":[{"key":"1848_CR1","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434\u20131441","journal-title":"N Engl J Med"},{"key":"1848_CR2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.7326\/0003-4819-146-5-200703060-00005","volume":"146","author":"SL Greenspan","year":"2007","unstructured":"Greenspan SL, Bone HG, Ettinger MP, Hanley DA, Lindsay R, Zanchetta JR, Blosch CM, Mathisen AL, Morris SA, Marriott TB (2007) Treatment of Osteoporosis with Parathyroid Hormone Study Group. Effect of recombinant human parathyroid hormone (1\u201384) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial. Ann Intern Med 146:326\u2013339","journal-title":"Ann Intern Med"},{"key":"1848_CR3","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa031975","volume":"349","author":"DM Black","year":"2003","unstructured":"Black DM, Greenspan SL, Ensrud KE, Palermo L, McGowan JA, Lang TF, Garnero P, Bouxsein ML, Bilezikian JP, Rosen CJ (2003) PaTH Study Investigators. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 349:1207\u20131215","journal-title":"N Engl J Med"},{"key":"1848_CR4","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa035725","volume":"349","author":"JS Finkelstein","year":"2003","unstructured":"Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM (2003) The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med 349:1216\u20131226","journal-title":"N Engl J Med"},{"key":"1848_CR5","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1210\/er.2004-0006","volume":"26","author":"AB Hodsman","year":"2005","unstructured":"Hodsman AB, Bauer DC, Dempster DW, Dian L, Hanley DA, Harris ST, Kendler DL, McClung MR, Miller PD, Olszynski WP, Orwoll E, Yuen CK (2005) Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev 26:688\u2013703","journal-title":"Endocr Rev"},{"key":"1848_CR6","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1056\/NEJMoa071408","volume":"357","author":"KG Saag","year":"2007","unstructured":"Saag KG, Shane E, Boonen S, Mar\u00edn F, Donley DW, Taylor KA, Dalsky GP, Marcus R (2007) Teriparatide or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med 357:2028\u20132039","journal-title":"N Engl J Med"},{"key":"1848_CR7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(97)06478-7","volume":"351","author":"N Kerkar","year":"1998","unstructured":"Kerkar N, Hadzic N, Davies ET, Portmann B, Donaldson PT, Rela M, Heaton ND, Vergani D, Mieli-Vergani G (1998) De-novo autoimmune hepatitis after liver transplantation. Lancet 351:409\u2013413","journal-title":"Lancet"},{"key":"1848_CR8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1399-0012.2007.00787.x","volume":"22","author":"K Yoshizawa","year":"2008","unstructured":"Yoshizawa K, Shirakawa H, Ichijo T, Umemura T, Tanaka E, Kiyosawa K, Imagawa E, Matsuda K, Hidaka E, Sano K, Nakazawa Y, Ikegami T, Hashikura Y, Miyagawa S, Ota M, Nakano M (2008) De novo autoimmune hepatitis following living-donor liver transplantation for primary biliary cirrhosis. Clin Transplant 22:385\u2013390","journal-title":"Clin Transplant"},{"key":"1848_CR9","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/lt.21721","volume":"15","author":"M Salcedo","year":"2009","unstructured":"Salcedo M, Rodr\u00edguez-Mahou M, Rodr\u00edguez-Sainz C, Rinc\u00f3n D, Alvarez E, Vicario JL, Catalina MV, Matilla A, Ripoll C, Clemente G, Ba\u00f1ares R (2009) Risk factors for developing de novo autoimmune hepatitis associated with anti-glutathione S-transferase T1 antibodies afterliver transplantation. Liver Transpl 15:530\u2013539","journal-title":"Liver Transpl"},{"key":"1848_CR10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/gut.2006.092064","volume":"56","author":"S Berardi","year":"2007","unstructured":"Berardi S, Lodato F, Gramenzi A, D'Errico A, Lenzi M, Bontadini A, Morelli MC, Tame MR, Piscali F, Biseli M, Sama C, Mazzella G, Pinna AD, Grazi G, Bernardi M, Andreone P (2007) High incidence of allograft dysfunction in liver transplant patients treated with Peg-interferon alfa-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis? Gut 56:237\u2013242","journal-title":"Gut"},{"key":"1848_CR11","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1210\/jc.2009-0205","volume":"94","author":"PR Ebeling","year":"2009","unstructured":"Ebeling PR (2009) Approach to the patient with transplantation-related bone loss. J Clin Endocrinol Metab 94:1483\u20131490","journal-title":"J Clin Endocrinol Metab"},{"key":"1848_CR12","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.TP.0000132328.33460.43","volume":"78","author":"A Miyagawa-Hayashino","year":"2004","unstructured":"Miyagawa-Hayashino A, Haga H, Egawa H, Hayashino Y, Sakurai T, Minamiguchi S, Tanaka K, Manabe T (2004) Outcome and risk factors of de novo autoimmune hepatitis in living-donor liver transplantation. Transplantation 78:128\u2013135","journal-title":"Transplantation"},{"key":"1848_CR13","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1016\/j.transproceed.2010.08.062","volume":"42","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Wang B, Wang T (2010) De novo autoimmune hepatitis with centrilobular necrosis following liver transplantation for primary biliary cirrhosis: a case report. Transplant Proc 42:3854\u20133857","journal-title":"Transplant Proc"},{"key":"1848_CR14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/jhep.2002.31167","volume":"35","author":"M Salcedo","year":"2002","unstructured":"Salcedo M, Vaquero J, Ba\u00f1ares R, Rodr\u00edguez-Mahou M, Alvarez E, Vicario JL, Hern\u00e1ndez-Alb\u00fajar A, T\u00edscar JL, Rinc\u00f3n D, Alonso S, De Diego A, Clemente G (2002) Response to steroids in de novo autoimmune hepatitis after liver transplantation. Hepatology 35:349\u2013356","journal-title":"Hepatology"},{"key":"1848_CR15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1053\/jlts.2001.23792","volume":"7","author":"CK Tan","year":"2001","unstructured":"Tan CK, Sian Ho JM (2001) Concurrent de novo autoimmune hepatitis and recurrence of primary biliary cirrhosis post-liver transplantation. Liver Transpl 7:461\u2013465","journal-title":"Liver Transpl"},{"key":"1848_CR16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1172\/JCI110053","volume":"67","author":"GV Segre","year":"1981","unstructured":"Segre GV, Perkins AS, Witters LA, Potts J Jr (1981) Metabolism of parathyroid hormone by isolated rat Kupffer cells and hepatocytes. J Clin Invest 67:449\u2013457","journal-title":"J Clin Invest"},{"key":"1848_CR17","doi-asserted-by":"crossref","first-page":"E405","DOI":"10.1152\/ajpendo.2001.280.3.E405","volume":"280","author":"MA Mitnick","year":"2001","unstructured":"Mitnick MA, Grey A, Masiukiewicz U, Bartkiewicz M, Rios-Velez L, Friedman S, Xu L, Horowitz MC, Insogna K (2001) Parathyroid hormone induces hepatic production of bioactive interleukin-6 and its soluble receptor. Am J Physiol Endocrinol Metab 280:E405\u2013E412","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1848_CR18","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.3748\/wjg.14.3306","volume":"14","author":"D Vergani","year":"2008","unstructured":"Vergani D, Mieli-Vergani G (2008) Aetiopathogenesis of autoimmune hepatitis. World J Gastroenterol 14:3306\u20133312","journal-title":"World J Gastroenterol"},{"key":"1848_CR19","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/00042737-200505000-00019","volume":"17","author":"LM Wolters","year":"2005","unstructured":"Wolters LM, Van Buuren HR (2005) Rosuvastatin-associated hepatitis with autoimmune features. Eur J Gastroenterol Hepatol 17:589\u2013590","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-011-1848-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-011-1848-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-011-1848-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T02:25:09Z","timestamp":1560997509000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-011-1848-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,26]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["1848"],"URL":"https:\/\/doi.org\/10.1007\/s00198-011-1848-y","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,26]]}}}